Mpm Bioimpact LLC’s Monte Rosa Therapeutics Inc Position
Does Mpm Bioimpact LLC own Monte Rosa Therapeutics Inc (GLUE)? Yes — 1.18M shares worth $19M (+1.50% of its 13F portfolio) as of Q1 2026, up from 1.17M shares the prior filed quarter.
Position Value
$19M
Q1 2026
Shares
1.18M
% of Portfolio
+1.50%
Quarters Held
2
currently held
Position History GLUE
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of GLUE.